Cavex Holland B.V. – FDA 483, Mar 5, 2020
An FDA inspection of Cavex Holland B.V., a manufacturer in Haarlem, Netherlands, identified three significant quality system deficiencies. The firm's MDR procedure lacked a standardized review process for adverse event reporting, and two complaints meeting reporting criteria were not submitted. Additionally, management review procedures were not adequately established, failing to report supplier performance, and procedures for ensuring purchased products and services conform to requirements were deficient, as evidenced by a lack of documentation for calibration service provider evaluations.
ID · 29fa37e7-ed8a-437e-aa6a-936ad0b66cd1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.